“Molnupiravir and Favipiravir in the therapeutics of SARS-CoV-2 - A review” (2023) Indian Journal of Pharmacy & Drug Studies, 1(3), pp. 73–78. Available at: https://mansapublishers.com/index.php/ijpds/article/view/3575 (Accessed: 29 April 2025).